Antitumor Activity of Garcinol in Human Prostate Cancer Cells and Xenograft Mice

被引:36
|
作者
Wang, Yu [1 ]
Tsai, Mei-Ling [2 ]
Chiou, Li-Yu [2 ]
Ho, Chi-Tang [4 ]
Pan, Min-Hsiung [3 ,5 ,6 ]
机构
[1] Univ Florida, Dept Food Sci & Human Nutr, Ctr Citrus Res & Educ, Lake Alfred, FL 33850 USA
[2] Natl Kaohsiung Marine Univ, Dept Seafood Sci, Kaohsiung 811, Taiwan
[3] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan
[4] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA
[5] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan
[6] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan
关键词
garcinol; apoptosis; autophagy; prostate cancer cells and xenograft mice; AUTOPHAGY; APOPTOSIS; CASPASES; DEATH; ACTIVATION; SURVIVAL; PROGRESS;
D O I
10.1021/acs.jafc.5b03851
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Garcinol, which is isolated from fruit rinds of Garcinia indica, is a polyisoprenylated benzophenone. It has been studied for its antitumor activity by inducing apoptosis and inhibiting autophagy in human prostate cancer cells. The Bax/Bcl-2 ratio increased when garcinol was applied to PC-3 cells indicating a presence of apoptosis. Meanwhile, procaspases-9 and -3 were suppressed with attenuating PARP and DFF-45. Autophagy was inhibited through activating p-mTOR and p-PI3 Kinase/AKT by garcinol, which as a result induced the cells to apoptosis directly. In addition, the apoptosis effect of garcinol in a xenograft mouse model was also tested, suggesting a consistent result with PC-3 cell model. The tumor size was reduced more than 80 percent after the mouse accepted the garcinol treatment. Garcinol was demonstrated to have a strong antitumor activity through inhibiting autophagy and inducing apoptosis, which was discovered for the first time. Based on these findings, our data suggests that garcinol deserves further investigation as a potent chemopreventive agent.
引用
收藏
页码:9047 / 9052
页数:6
相关论文
共 50 条
  • [1] Anti-PSMA immunotoxin as novel treatment for prostate cancer?: High and specific antitumor activity on human prostate xenograft tumors in SCID mice
    Wolf, Philipp
    Alt, Karen
    Buehler, Patrick
    Katzenwadel, Arndt
    Wetterauer, Ulrich
    Tacke, Marlene
    Elsaesser-Beile, Ursula
    PROSTATE, 2008, 68 (02): : 129 - 138
  • [2] Antitumor activity of PSMA ADC after progression on docetaxel in a mouse xenograft model of human prostate cancer
    Ma, D.
    Zhang, H.
    Kennedy, B.
    Parsons, T.
    Olson, W. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Antitumor activity of cytotropic heterogeneous molecular lipids (CHML) on human breast cancer xenograft in nude mice
    Zhan, QM
    Zhao, SC
    Xu, Z
    ANTICANCER RESEARCH, 2001, 21 (4A) : 2477 - 2482
  • [4] Antitumor activity of herbal supplements in human prostate cancer xenografts implanted in immunodeficient mice
    Ng, SSW
    Figg, WD
    ANTICANCER RESEARCH, 2003, 23 (5A) : 3585 - 3590
  • [5] Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft
    Bandyopadhyay, A
    López-Casillas, F
    Malik, SN
    Montiel, JL
    Mendoza, V
    Yang, JH
    Sun, LZ
    CANCER RESEARCH, 2002, 62 (16) : 4690 - 4695
  • [6] Antitumor activity of MGI 114 against two human prostate tumor xenograft models
    Mangold, G
    MacDonald, J
    Von Hoff, D
    Weitman, S
    ANNALS OF ONCOLOGY, 1998, 9 : 37 - 37
  • [7] The Synergistic Antitumor Effect of Irinotecan and Flavonoids on Human Colon Cancer Xenograft Mice
    Godavarthi, Jyotsna Devi
    Williams-Villalobo, Abie
    Etim, Imoh
    Ting, Du
    Gao, Song
    Zhang, Yun
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [8] FoxO transcription factors regulate antitumor activity of resveratrol in human prostate cancer cells
    Shankar, Sharmila
    Chen, Quinghe
    Suthakar, Ganapathi
    Srivastava, Rakesh
    CANCER RESEARCH, 2009, 69
  • [9] Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models
    Fujimoto-Ouchi, Kaori
    Sekiguchi, Fumiko
    Yasuno, Hideyuki
    Moriya, Yoichiro
    Mori, Kazushige
    Tanaka, Yutaka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 795 - 805
  • [10] Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models
    Kaori Fujimoto-Ouchi
    Fumiko Sekiguchi
    Hideyuki Yasuno
    Yoichiro Moriya
    Kazushige Mori
    Yutaka Tanaka
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 795 - 805